Maia Biotechnology Inc MAIA

$1.19 +0.02 (1.71%)

Valuation

Market cap
73,473,000
Revenue TTM
$0
Net income TTM
$-22,400,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
405,000
Avg volume
505,490
Day's range
$1.17 – $1.21
Shares out
61,742,000
Stochastic %K
18%
Beta
0.27
Analysts
Sell
Price target
$12.00

Price

Company profile

MAIA Biotechnology, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the development of targeted immunotherapies for cancer. Its lead product Ateganosine, a telomere-targeting agent currently in clinical development to evaluate its activity in Non-Small Cell Lung Cancer (NSCLC). The company was incorporated in 2018 and is headquartered in Chicago, Illinois.

Industry
Biotechnology
Sector
Healthcare
Phone
312 416 8592
Website
https://maiabiotech.com
Address
444 West Lake Street, Suite 1700, Chicago, United States

Latest news

No headlines yet.

Stocktwits

Chemaster Oct 4, 5:36 PM
$MAIA I created the folloing MAIA Stock Tool — built with ChatGPT to explore buy and sell scenarios. See how trades affect your remaining shares, recovered cash, and break-even price. Save your own scenarios. All data is saved saved locally on your PC so is not shared on server. Planning tool only; results may contain errors. Not investment advice. https://maia-stock-sim.chemaster.chatgpt.site
0 replies
GISBlaster98 Oct 3, 12:23 PM
$MAIA Just ran across this… while a little dated ( few months old) I think it is an excellent overview of MAIA. https://www.reddit.com/r/biotech_stocks/comments/1wb4jy7/maia_an_80m_phase_3_oncology_company_with/
0 replies
MoneyHelix Oct 2, 8:16 PM
$MAIA ANOTHER ONE 🥂
4 replies
MoneyHelix Oct 1, 8:03 PM
$MAIA It's October. The Prix Galean is in exactly 4 weeks 🥂 We'll be fully visible to all top decision-makers in Pharma 💰🪙
1 replies
Bateman84 Oct 1, 5:58 PM
$MAIA What does everyone here think about the real 3l NSCLC population being much lower than 50k patients? After going over it with Claude AI, it seems to think it is more like 11-15k in the US. This is what potential buyers look at. Not sure where Vlad is getting 50k from?
6 replies
dragonbits Oct 1, 5:38 PM
$MAIA All is calm, but Poc can't sell any shares until the EFFECT filing is issued. At this point, no idea how that will work.
2 replies
Chemaster Oct 1, 10:15 AM
$MAIA Promise, I am not affiliated with this site and seems mostly accurate. https://bioradar.io/stock/MAIA/
2 replies
Juhanialainen Oct 1, 4:12 AM
$VERA $CING $MAIA $BCTX $PYPD We are soft launching a comprehensive one-solution-to-cover-all-needs biotech investing service powerhouse — http://bioradar.io. This is BIG! The monthly price is insanely cheap, at least for now and you’ll get free 7 day trial to test it out risk free. I’m a partner in this 🇫🇮 based service as a Brand Ambassador & Senior Advisor and been involved in developing this service for the last few months in silence. Now the service is ready. We’ve built dozens of APIs to major data sources like Edgar for example for SEC filings, we have built-in PDUFA date calendar, dilution tracking, company cash situation, price volatility and social buzz alerts directly into your email and dozens of other features that a biotech investor needs. All in one place with just a few dollars per month. Check it out, try it free and let me know what you think?
1 replies